These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1273534)

  • 21. Bone mineral content in myelomatosis.
    Ingeberg S; Deding A; Jensen MK
    Acta Med Scand; 1982; 211(1-2):19-21. PubMed ID: 7072520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1 alpha-hydroxy vitamin D3 treatment of non-dialyzed patients with chronic renal failure. Effects on bone, mineral metabolism and kidney function.
    Nielsen HE; Rømer FK; Melsen F; Christensen MS; Hansen HE
    Clin Nephrol; 1980 Mar; 13(3):103-8. PubMed ID: 7379358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mineral content of the skeleton in chronic kidney insufficiency treated with dialysis and after kidney transplantation. Results of isotope densitometry].
    Mujagic M; Flury W; Descoeudres C; Montandon A; Debrunner HU
    Schweiz Med Wochenschr; 1977 Oct; 107(42):1487-92. PubMed ID: 335506
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationships of serum levels of insulinlike growth factors with indices of bone metabolism and nutritional conditions in hemodialysis patients.
    Nanba K; Nagake Y; Miyatake N; Nakao K; Akagi S; Sugimoto T; Yamasaki H; Oishi K; Ichikawa H; Makino H
    Nephron; 2001 Oct; 89(2):145-52. PubMed ID: 11549896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of bone mineral content determination in the evaluation of osteodystrophy among hemodialysis patients.
    Heaf JG; Nielsen LP; Mogensen NB
    Nephron; 1983; 35(2):103-7. PubMed ID: 6621754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone mineral content in patients with primary hyperparathyroidism without radiological evidence of skeletal changes.
    Dalén N; Hjern B
    Acta Endocrinol (Copenh); 1974 Feb; 75(2):297-304. PubMed ID: 4406546
    [No Abstract]   [Full Text] [Related]  

  • 27. Total and local bone mineral during estrogen treatment: a placebo controlled trial.
    Gotfredsen A; Riis BJ; Christiansen C
    Bone Miner; 1986 Apr; 1(2):167-73. PubMed ID: 3334206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of bone Gla-protein in normal humans and in patients with chronic renal failure.
    Sugimoto K; Dohi Y; Dohi K; Yonemasu K; Fujimoto J; Kanauchi M; Yamanaka F; Moriyama T; Ishikawa H
    Miner Electrolyte Metab; 1987; 13(3):152-7. PubMed ID: 3498115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment.
    Coen G; Mazzaferro S; Costantini S; Ballanti P; Carrieri MP; Giordano R; Smacchi A; Sardella D; Bonucci E; Taggi F
    Miner Electrolyte Metab; 1989; 15(5):295-302. PubMed ID: 2811788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical significance of direct measurement of bone mineral content. 125I photon absorption measurement in 1252 cases].
    Ringe JD
    Fortschr Med; 1983 Feb; 101(5):186-90. PubMed ID: 6832681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between local and total bone mineral in normal pubertal boys.
    Krabbe S; Gotfredsen A; Christiansen C
    Eur J Pediatr; 1984 Dec; 143(2):149-51. PubMed ID: 6335091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Calcium homeostasis, calcium metabolism and bone changes in chronic kidney failure].
    Gossmann HH; Schaumlöffel E
    Verh Dtsch Ges Inn Med; 1968; 74():445-8. PubMed ID: 5714363
    [No Abstract]   [Full Text] [Related]  

  • 33. Deterring bone loss by exercise intervention in premenopausal and postmenopausal women.
    Smith EL; Gilligan C; McAdam M; Ensign CP; Smith PE
    Calcif Tissue Int; 1989 May; 44(5):312-21. PubMed ID: 2496902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone aluminium in haemodialysed patients and in rats injected with aluminium chloride: relationship to impaired bone mineralisation.
    Ellis HA; McCarthy JH; Herrington J
    J Clin Pathol; 1979 Aug; 32(8):832-44. PubMed ID: 389958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bisphosphonate whole body retention test: relations to bone mineralization rate, renal function and bone mineral content in osteoporosis and metabolic bone disorders.
    Mosekilde L; Hasling C; Tågehøj Jensen PC; Tågehøj Jensen F
    Eur J Clin Invest; 1987 Dec; 17(6):530-7. PubMed ID: 3123252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantation.
    Giannini S; D'Angelo A; Carraro G; Antonello A; Di Landro D; Marchini F; Plebani M; Zaninotto M; Rigotti P; Sartori L; Crepaldi G
    Clin Nephrol; 2001 Nov; 56(5):353-63. PubMed ID: 11758005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone demineralization in renal failure: a longitudinal study of the distal femur using photon absorptiometry.
    Overton TR; Silverberg DS; Grace M; Rigal WM; Higgins M; Bettcher KB; Dossetor JB; Harley H; DeLuca HF
    Br J Radiol; 1976 Nov; 49(587):921-5. PubMed ID: 1009305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mineral metabolism in chronic renal failure with special reference to serum concentrations of 1.25(OH)2D and 24.25(OH)2D.
    Christiansen C; Christensen MS; Melsen F; Rødbro P; DeLuca HF
    Clin Nephrol; 1981 Jan; 15(1):18-22. PubMed ID: 7214748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone mineral content in chronic renal failure and after renal transplantation.
    Dalén N; Alvestrand A
    Clin Nephrol; 1973; 1(6):338-46. PubMed ID: 4594997
    [No Abstract]   [Full Text] [Related]  

  • 40. [Bone mineral content during chronic hemodialysis long term observation by 125-i photonabsorptiometry (author's transl)].
    Kuhlencordt F; Ringe JD
    Klin Wochenschr; 1978 Jan; 56(2):75-9. PubMed ID: 415174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.